Signal active
Organization
Contact Information
Overview
OncoNano Medicine is a biotech company that develops nanotechnology-enabled fluorescent probes to help cancer surgeons visualize tumors during surgery, allowing them to excise tumors more precisely. The fluorescent sensor targets the different pH signals, thus making them glow so they are easier to distinguish from normal tissue.
OncoNano Medicine is a UTSW spinoff company based in Dallas, Texas.
About
Biotechnology, Health Care, Nanotechnology, Alternative Medicine
2014
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Onconano Medicine headquartered in United States, North America, operates in the Biotechnology, Health Care, Nanotechnology, Alternative Medicine sector. The company focuses on Biotechnology and has secured $21.1B in funding across 112 round(s). With a team of 11-50 employees, Onconano Medicine is actively contributing to advancements in Biotechnology. Their latest funding round, Grant - Onconano Medicine, raised $6.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
7
1
0
$188.1M
Details
4
Onconano Medicine has raised a total of $188.1M in funding over 4 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2018 | Early Stage Venture | 11.7M | ||
2019 | Early Stage Venture | 23.7M | ||
2021 | Early Stage Venture | 50.0M | ||
2021 | Early Stage Venture | 18.4M |
Investors
Onconano Medicine is funded by 15 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
Onconano Medicine | - | FUNDING ROUND - Onconano Medicine | 68.4M |
Salem Partners | - | FUNDING ROUND - Salem Partners | 68.4M |
Onconano Medicine | - | FUNDING ROUND - Onconano Medicine | 6.0M |
Cancer Prevention and Research Institute of Texas | - | FUNDING ROUND - Cancer Prevention and Research Institute of Texas | 6.0M |
Recent Activity
There is no recent news or activity for this profile.